Back

Upregulation of galectin-3 in relation to the severity of cardiomyopathy due to transgenic beta-adrenergic activation

30 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Integrative physiology and pathology Integrative physiology and control mechanisms ESC Premium Access ESC Congress 2016

About the speaker

Photo
Ms My-Nhan Nguyen

Baker Heart and Diabetes Institute, Melbourne (Australia)

15 More presentations in this session

Presentation thumbnail
Ms A. Di Bona (Padova, IT)
Presentation thumbnail
Doctor P. Niewinski (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Doctor R. Da Costa Adao (Madrid, ES)
Abstract
Presentation thumbnail
Doctor S. Tubek (Wroclaw, PL)
Abstract
Presentation thumbnail
Doctor T. Zaglia (Padova, IT)

Access the full session

Session thumbnail
Poster session 6 - Integrative physiology and pathology

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Galectin-3 predicts the risk of ventricular tachycardia in ischemic heart failure patients with implantable cardioverter-defibrillator
30 June 2021
thumbnail
Congress Presentation
Beta3 adrenergic receptors: where, and what for?
28 August 2022
thumbnail
Congress Presentation
Methylglyoxal induces cardiac dysfunction through mechanisms involving impaired calcium homeostasis in rats
22 May 2023
thumbnail
Congress Session
Genetics in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources